In this episode, we are joined by pulmonologist, Dr. Amy Malik and uveitis specialist, Dr. Ananth Sastry to discuss the ocular and systemic considerations in sarcoidosis.

The discussant report no relevant financial disclosures.

In this episode, we are joined by Drs. Lucia Sobrin and Tim Boyce to discuss the perplexing condition that is autoimmune retinopathy.

The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Meghan Berkenstock and Meredith McKean to discuss uveitis secondary to immune checkpoint inhibtor use.

In this episode, we are joined by Drs. John Kempen and Sapna Gangaputra to review the many ways the SITE cohort study has shaped the way we approach uveitis.

Drs. Kempen and Gangaputra have received grant support from the NIH for their work on the SITE cohort study.

In this episode we are joined by Drs. Debra Goldstein and Mark Dacey to discuss the manifestations, treatment approach and special considerations for ocular syphilis.

The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Jennifer Thorne and Parisa Emami to discuss diagnostic and therapeutic approaches in the management of uveitic CNV.

Disclosures:
Dr. Kopplin: None
Dr. Thomas: Consultant for Allergan, Genentech
Dr. Thorne: None
Dr. Emami: Consultant for Genentech

Here we are joined by Drs. Justine Smith and Emilio Dodds to discuss the clinical features and treatment approach in toxoplasma chorioretinitis.

The discussants report no relevant financial disclosures.

In this episode, we are joined by Drs. Alan Palestine and Karen Armbrust to discuss the approach the diagnosis and managament of the many forms of scleritis.

The discussants report no relevant financial disclosures.